Blog

Home » Blog

VIDEO: Dr. Laurence Klotz, “Navigating treatment options for localized prostate cancer”

Videos, Awareness Nights, Active Surveillance, Focal Therapy / By / / 1 minute of reading

  January 2013 Scotiabank Awateness Night Dr.Laurence Klotz, MD, FRCSC Professor, Department of Surgery, University of Toronto Chief, Division of Urology, Sunnybrook Health Sciences Centre Chair, Canadian Uro-Oncology Group and NCIC GU Site Group Editor in Chief (founding), Canadian Journal of Urology Chair, Global GU Oncology Group For localized prostate cancer, the choice of treatment is becoming less straightforward as preferences shift to less aggressive, less intrusive, and increasingly sophisticated approaches. This presentation provides guidance and insight…with focus on active surveillance, focal therapy, MRI imaging, and recent developments in surgery. CLICK ON THE ARROW TO START THE VIDEO  “Navigating treatment […]

VIDEO: Dr. Laurence Klotz, “Navigating treatment options for localized prostate cancer” Read More »

Tea May Lower Prostate Cancer Risk

Diet / By / / 1 minute of reading

New findings add to mounting evidence suggesting that tea consumption may lower the risk of developing prostate cancer. The findings are based on a population-based case-control study conducted in King County, Washington. The study, by Milan S. Geybels, MSc, of the Department of Epidemiology, Maastricht University, Maastricht, The Netherlands, and colleagues examined associations between PCa risk and tea and coffee consumption. The tea-related analysis focused on 863 PCa cases and 863 controls; the coffee-related analysis included 894 cases and 860 controls. Read the article.

Tea May Lower Prostate Cancer Risk Read More »

New prostate cancer test could change treatment.

Diagnosis / By / / 1 minute of reading

Schulich School of Medicine & Dentistry professor Hon Leong has developed a new blood test which could detect the potential for prostate cancer earlier. Thousands of men face a prostate biopsy following higher-than-normal results from their annual prostate-specific antigen (PSA) test, the traditional screening for prostate cancer. But recent studies have shown three in four of these biopsies were unnecessary, leading to 165,000 unnecessary procedures and 6,930 related hospitalizations each year. Read more at: http://medicalxpress.com/news/2013-02-prostate-cancer-treatment.html#jCp

New prostate cancer test could change treatment. Read More »

Recent Developments in Treatments for Metastatic Castration-resistant Prostate Cancer—A Mechanistic Perspective

Advanced Prostate Cancer / By / / 1 minute of reading

Abstract Over the past decade, the treatment landscape in metastatic castration-resistant prostate cancer (CRPC) has markedly changed, with the introduction of three new chemotherapeutic agents. The mechanism of CRPC is not fully understood, but it may result from multiple pathways, including a loss or androgen receptor (AR) specificity and increased downstream signalling activity that provide multiple targets for therapeutic agents. For some years, docetaxel was the mainstay of treatment in CRPC, but recently, cabazitaxel (a microtubule inhibitor), sipuleucel-T (a cancer vaccine), and abiraterone acetate (a CYP17 inhibitor) were approved for CRPC treatment. In Phase III clinical trials, these agents have

Recent Developments in Treatments for Metastatic Castration-resistant Prostate Cancer—A Mechanistic Perspective Read More »

Emotional Stress Reduces Effectiveness of Prostate Cancer Therapies in Animal Model

Psychology / By / / 1 minute of reading

Not surprisingly, a cancer diagnosis creates stress. And patients with prostate cancer show higher levels of anxiety compared to other cancer patients. A new study by researchers at Wake Forest Baptist Medical Center indicates that stress is not just an emotional side effect of the diagnosis; it also can reduce the effectiveness of prostate cancer drugs and accelerate the development of prostate cancer. Read the article.

Emotional Stress Reduces Effectiveness of Prostate Cancer Therapies in Animal Model Read More »

PSA Levels Higher in Sedentary Men

Diagnosis, Exercise / By / / 1 minute of reading

PSA concentrations are higher in men who engage in more sedentary behavior and lower levels of light physical activity, a study found. It is hypothesized that regular participation in physical activity may reduce prostate cancer risk through a variety of biological mechanisms including changes in energy balance, immune function, inflammation, antioxidant defenses, and endogenous hormones. Based on their results, the authors stated, evaluation of a patient’s physical activity and sedentary level before PSA testing also is important because these factors also may influence measurements and lead to a urologic diagnostic workup. Read the whole article.

PSA Levels Higher in Sedentary Men Read More »

Artificial Urinary Sphincter Implantation for Post-RP Urinary Incontinence

Incontinence / By / / 1 minute of reading

Most men with incontinence following RP have normal bladder function; their incontinence is usually due to intrinsic sphincteric urethral deficiency. When urodynamic study confirms this diagnosis and flexible cystoscopy, shows no significant urethral stricture, artificial urinary sphincter implantation is indicated. Read the Article.

Artificial Urinary Sphincter Implantation for Post-RP Urinary Incontinence Read More »

VIDEO: Dr. Padrick Warde, “Radiation Therapy for Prostate Cancer in 2012 and beyond.”

Videos, Awareness Nights, Radiation / By / / 1 minute of reading

November 2012 Awareness Night “Radiation Therapy for Prostate Cancer in 2012 and beyond.” Dr. Padrick Warde, MD, MCChB BAO, FRCPC Professor, Department of Radiation Oncology, University of Toronto Staff Radiation Oncologist, The Princess Margaret Cancer Centre/University Health Network Associate Director, Radiation Medicine Program, The Princess Margaret Cancer Centre CLICK ON THE ARROW TO START THE VIDEO Complete Presentation “Radiation Therapy for Prostate Cancer in 2012 and beyond.” High Definition 49inutes Click here to return to top. Click here to return to our main “Videos” page.

VIDEO: Dr. Padrick Warde, “Radiation Therapy for Prostate Cancer in 2012 and beyond.” Read More »

Scroll to Top